142 related articles for article (PubMed ID: 28595131)
21. Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.
Li X; Wu M; Pan L; Shi J
Int J Nanomedicine; 2016; 11():93-105. PubMed ID: 26766908
[TBL] [Abstract][Full Text] [Related]
22. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway.
Fan Y; Peng A; He S; Shao X; Nie C; Chen L
J Chemother; 2013 Oct; 25(5):298-308. PubMed ID: 24070138
[TBL] [Abstract][Full Text] [Related]
23. The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention.
Renziehausen A; Wang H; Rao B; Weir L; Nigro CL; Lattanzio L; Merlano M; Vega-Rioja A; Del Carmen Fernandez-Carranco M; Hajji N; Matin R; Harwood C; Li S; Sim VR; O'Neill K; Evans A; Thompson A; Szlosarek P; Fleming C; Stebbing J; Proby C; Tzakos AG; Syed N; Crook T
Oncogene; 2019 Mar; 38(13):2320-2336. PubMed ID: 30478450
[TBL] [Abstract][Full Text] [Related]
24. Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer.
Herr D; Rodewald M; Fraser HM; Hack G; Konrad R; Kreienberg R; Wulff C
Gynecol Oncol; 2008 Jun; 109(3):418-25. PubMed ID: 18395779
[TBL] [Abstract][Full Text] [Related]
25. Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin.
Cao Y; Huang HY; Chen LQ; Du HH; Cui JH; Zhang LW; Lee BJ; Cao QR
ACS Appl Mater Interfaces; 2019 Mar; 11(10):9763-9776. PubMed ID: 30776886
[TBL] [Abstract][Full Text] [Related]
26. Tumor-targeting and microenvironment-responsive smart nanoparticles for combination therapy of antiangiogenesis and apoptosis.
Huang S; Shao K; Liu Y; Kuang Y; Li J; An S; Guo Y; Ma H; Jiang C
ACS Nano; 2013 Mar; 7(3):2860-71. PubMed ID: 23451830
[TBL] [Abstract][Full Text] [Related]
27. Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis.
Kim WJ; Yockman JW; Lee M; Jeong JH; Kim YH; Kim SW
J Control Release; 2005 Aug; 106(1-2):224-34. PubMed ID: 15970348
[TBL] [Abstract][Full Text] [Related]
28. The Other Angiotensin II Receptor: AT
Juillerat-Jeanneret L
J Med Chem; 2020 Mar; 63(5):1978-1995. PubMed ID: 32030982
[TBL] [Abstract][Full Text] [Related]
29. The human duodenal mucosa harbors all components for a local renin angiotensin system.
Spak E; Hallersund P; Edebo A; Casselbrant A; Fändriks L
Clin Sci (Lond); 2019 Apr; 133(8):971-982. PubMed ID: 30988133
[TBL] [Abstract][Full Text] [Related]
30. Hybrid polymer-grafted multiwalled carbon nanotubes for in vitro gene delivery.
Nunes A; Amsharov N; Guo C; Van den Bossche J; Santhosh P; Karachalios TK; Nitodas SF; Burghard M; Kostarelos K; Al-Jamal KT
Small; 2010 Oct; 6(20):2281-91. PubMed ID: 20878655
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of corneal neovascularization by blocking the angiotensin II type 1 receptor.
Usui T; Sugisaki K; Iriyama A; Yokoo S; Yamagami S; Nagai N; Ishida S; Amano S
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4370-6. PubMed ID: 18829859
[TBL] [Abstract][Full Text] [Related]
32. The antiparasitic drug, potassium antimony tartrate, inhibits tumor angiogenesis and tumor growth in nonsmall-cell lung cancer.
Wang B; Yu W; Guo J; Jiang X; Lu W; Liu M; Pang X
J Pharmacol Exp Ther; 2015 Jan; 352(1):129-38. PubMed ID: 25352499
[TBL] [Abstract][Full Text] [Related]
33. Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart.
Siddiqui AJ; Mansson-Broberg A; Gustafsson T; Grinnemo KH; Dellgren G; Hao X; Fischer H; Sylvén C
Am J Hypertens; 2005 Oct; 18(10):1347-52. PubMed ID: 16202860
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin II promotes the progression of human gastric cancer.
Huang MM; Guo AB; Sun JF; Chen XL; Yin ZY
Mol Med Rep; 2014 Mar; 9(3):1056-60. PubMed ID: 24424956
[TBL] [Abstract][Full Text] [Related]
35. Clinically relevant doses of candesartan inhibit growth of prostate tumor xenografts in vivo through modulation of tumor angiogenesis.
Alhusban A; Al-Azayzih A; Goc A; Gao F; Fagan SC; Somanath PR
J Pharmacol Exp Ther; 2014 Sep; 350(3):635-45. PubMed ID: 24990940
[TBL] [Abstract][Full Text] [Related]
36. Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders.
Paulis L; Foulquier S; Namsolleck P; Recarti C; Steckelings UM; Unger T
Drugs; 2016 Jan; 76(1):1-12. PubMed ID: 26631237
[TBL] [Abstract][Full Text] [Related]
37. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
[TBL] [Abstract][Full Text] [Related]
38. Prevention of accelerated atherosclerosis by AT1 receptor blockade in experimental renal failure.
Bernardi S; Candido R; Toffoli B; Carretta R; Fabris B
Nephrol Dial Transplant; 2011 Mar; 26(3):832-8. PubMed ID: 20810455
[TBL] [Abstract][Full Text] [Related]
39. Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.
Liu YR; Guan YY; Luan X; Lu Q; Wang C; Liu HJ; Gao YG; Yang SC; Dong X; Chen HZ; Fang C
Biomaterials; 2015 Feb; 42():161-71. PubMed ID: 25542804
[TBL] [Abstract][Full Text] [Related]
40. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
